Replimune Appoints Tanya Lewis to the Board of Directors

NEXT STORY
ORIC Pharmaceuticals Expands Precision Oncology Pipeline with Exclusive License to Brain Penetrant EGFR/HER2 Exon 20 Inhibitor Program
PREV STORY
Inventiva receives FDA Fast Track designation in MPS VI for its clinical-stage asset odiparci
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA & Industry Veteran Brian E. Harvey, MD, PhD, Joins Thetis Pharmaceuticals as Senior Medical Director

Former FDA GI Division Director and V.P. of U.S. Regulatory Strategy at Pfizer to ...

author_avatar
NASDAQ Market News

OncoMed Provides 2018 Outlook and 2017 Year-End Cash Balance and Announces an Update on the Rosmantuzumab Program

Year-end 2017 Cash Balance of $103.1 Million Presentation of Clinical Data on Phase 1 ...

author_avatar
NASDAQ Market News

Diet Doc Announces Their All-Inclusive, Nationwide Medical Weight Loss Service that Enables Dieters Throughout the Country to Connect with the Best Minds in the Business for Safe and Fast Weight Loss

LOS ANGELES, Dec. 30, 2015 (GLOBE NEWSWIRE) -- For many Americans, finding a doctor ...

author_avatar
NASDAQ Market News